Skip to main content
logo
General Biologicals Corporation (TPEX:4117)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
10.50
0.00 (0.00%)
Jul 9, 2026, 2:59 PM CST

Revenue by Segment

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Medical Technology
43.51M70.24M158.27M129.73M182.85M
Medical Technology Growth
-38.06%-55.62%22.00%-29.05%31.83%
Adjustment and Elimination
-15.16M-8.12M-60.29M-44.57M-27.44M
Diagnostic Reagents
102.90M155.46M132.69M258.54M396.24M
Diagnostic Reagents Growth
-33.81%17.16%-48.68%-34.75%8.80%
Protein New Drug
54.68M34.34M34.14M26.76M-
Protein New Drug Growth
59.22%0.57%27.60%--
Lease Management
29.81M----
Total
215.74M251.93M264.83M370.46M551.66M
Total Growth
-14.36%-4.87%-28.51%-32.85%15.93%

Revenue by Geography

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Taiwan
124.10M93.78M174.86M228.94M189.23M
Taiwan Growth
32.33%-46.37%-23.62%20.99%27.41%
Europe
21.35M1.77M1.80M3.58M4.97M
Europe Growth
1108.32%-1.83%-49.71%-27.92%8.88%
Asia (Excluding Taiwan)
3.91M29.38M42.62M55.51M-
Asia (Excluding Taiwan) Growth
-86.68%-31.07%-23.23%--
North America
65.18M126.71M42.69M77.11M-
North America Growth
-48.56%196.82%-44.64%--
Other
1.20M296.00K2.86M5.32M-
Other Growth
303.72%-89.64%-46.31%--
America
----151.84M
America Growth
----18.52%
Asia and Others (Apart from Taiwan)
----223.98M
Asia and Others (Apart from Taiwan) Growth
----1.80%
Africa
----9.08M
Africa Growth
----275.87%
Internal Department Transaction Revenue
-----27.44M
Total
215.74M251.93M264.83M370.46M551.66M
Total Growth
-14.36%-4.87%-28.51%-32.85%15.93%